Richter Gedeon Earnings Estimate

Richter Gedeon Earnings per Share Projection vs Actual

About Richter Gedeon Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of Richter Gedeon earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current Richter Gedeon estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as Richter Gedeon fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Richter Gedeon Vegyszeti Gyr Nyilvnosan Mukdo Rt. researches, develops, manufactures, markets, and sells pharmaceutical products worldwide. The company was founded in 1901 and is headquartered in Budapest, Hungary. RICHT GEDE operates under Drug Manufacturers - Specialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 12869 people.

Currently Active Assets on Macroaxis

Other Information on Investing in Richter Stock

Richter Gedeon financial ratios help investors to determine whether Richter Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Richter with respect to the benefits of owning Richter Gedeon security.